FDA List of Authorized Generics: How to Find and Use It

Imagine finding a medication that is identical to a brand-name drug-made by the same company, in the same factory-but doesn't have the fancy brand name on the box. You might expect it to be listed in the same place as every other generic, but it's not. These are authorized generics, and because they follow a different legal path than traditional generics, they hide in a separate part of the FDA's database. If you're trying to lower your prescription costs or track market competitors, knowing exactly where to find this specific list is a game-changer. While a standard generic is a copy made by a different company, an authorized generic is essentially the brand-name drug in a generic's clothing. This is why they are considered therapeutically equivalent by default. However, because they don't use the ANDA process, you won't find them in the famous Orange Book. Instead, they live in a dedicated, quarterly-updated list maintained by the FDA.

How to access the FDA authorized generics list

Getting your hands on the list is straightforward, but you have to go to the right corner of the FDA website. The primary access point is the dedicated webpage for authorized generic drugs within the Abbreviated New Drug Application (ANDA) section of the FDA site. Once you land on the page, you'll find a link to a PDF document. As of the late 2025 updates, this file is roughly 1.09 MB. It's not a fancy searchable database yet-though the FDA is planning to move to a dynamic format by mid-2026-so for now, you'll be using "Ctrl+F" to find what you need. When you open the document, look for these specific columns:

• Proprietary Name: The original brand name of the drug.
• Dosage Form and Strength: Exactly how the drug is delivered (e.g., 50 mg tablet).
• NDA Applicant: The company that holds the original patent and is selling the authorized version.
• Date Authorized Generic Entered Market: This is a crucial point-this date refers to the annual report period, not necessarily the exact day the drug hit pharmacy shelves.

Authorized generics vs. traditional generics

It's easy to lump all generics together, but the difference between an "authorized" version and a "traditional" one is massive for manufacturers and sometimes for your wallet. A traditional generic must prove it is bioequivalent to the brand. An authorized generic doesn't have to prove this because it *is* the brand drug. One of the biggest differences is the 180-day marketing exclusivity period. Normally, the first traditional generic company to enter the market gets a six-month head start without competition. However, brand companies can launch an authorized generic immediately to blunt that impact.

The a-ha moments: Practical use and pitfalls

If you're a patient or a pharmacist, you might think the list is a goldmine for saving money. In reality, it's more of a research tool than a shopping list. There's a significant gap between what the FDA lists and what your local wholesaler actually has in stock. For instance, an independent pharmacist might see a drug on the list and try to order it, only to find it's unavailable. This is because the FDA doesn't track whether a drug is still being marketed; they only track that it *was* reported in an annual filing. To get a real-world picture, you have to cross-reference the FDA list with the National Drug Code (NDC) Directory or commercial data tools like IQVIA. If you're doing a deep dive, here is a pro tip: combine the authorized generics list with the FDA Electronic Drug Registration and Listing System. This helps fill in the gaps left by incomplete annual reports, which some experts estimate could hide up to 15% of authorized generics from the main list.

Who is driving this market?

Not all companies use this strategy. It's primarily a tool for the giants. Companies like Pfizer, Teva, and Viatris (formerly Mylan) are among the most active. In recent lists, Pfizer alone has been responsible for nearly 50 distinct authorized generic products. Why do they do it? It's about market share. When a patent expires and a traditional generic company tries to swoop in, the brand company releases the authorized generic to keep customers within their ecosystem and maintain some control over the pricing. While some argue this keeps prices slightly higher than they would be with only traditional generics, others, like Professor Richard T. Epstein, suggest it actually prevents traditional generic companies from overcharging during that 180-day exclusivity window.

Common mistakes when using the FDA data

Avoid treating the "Date Entered Market" column as a precise calendar date. Because the FDA relies on annual reports, that date is often a broad window. If you see a date from 2012, the drug might have actually launched in late 2011 or early 2012. Another mistake is looking for these drugs in the Orange Book. If a brand drug is "single source" (meaning no traditional generics are approved), you might think no cheaper version exists. But if you check the authorized generics list, you might find a version that is exactly the same but costs significantly less. Always check both resources to get the full picture.

Next steps for verification

If you've found a potential medication on the list, don't stop there. Follow these steps to ensure it's actually available and right for you:

1. Verify the NDC: Use the National Drug Code Directory to find the specific identifier for the authorized generic.
2. Check with Wholesalers: If you're a provider, check your primary wholesaler's live inventory to see if the drug is currently in stock.
3. Compare with the Orange Book: See if there are traditional generics available; sometimes a traditional generic is even cheaper than the authorized one.
4. Consult your Pharmacist: Ask specifically for the "authorized generic" version of your brand-name med to see if your insurance covers it.